MCID: HMG010
MIFTS: 18

Hemoglobinemia malady

Categories: Rare diseases, Blood diseases

Aliases & Classifications for Hemoglobinemia

About this section

Aliases & Descriptions for Hemoglobinemia:

Name: Hemoglobinemia 45 47 65
 
Haemoglobinemia 45

Classifications:



External Ids:

UMLS65 C0235573

Summaries for Hemoglobinemia

About this section
Wikipedia:68 Hemoglobinemia (British Haemoglobinaemia) is a medical condition in which there is an excess of... more...

MalaCards based summary: Hemoglobinemia, also known as haemoglobinemia, is related to prostatitis and basal cell carcinoma. An important gene associated with Hemoglobinemia is HP (Haptoglobin), and among its related pathways is Binding and Uptake of Ligands by Scavenger Receptors. Affiliated tissues include bone, testes and liver.

Related Diseases for Hemoglobinemia

About this section

Graphical network of the top 20 diseases related to Hemoglobinemia:



Diseases related to hemoglobinemia

Symptoms for Hemoglobinemia

About this section

Drugs & Therapeutics for Hemoglobinemia

About this section

Drugs for Hemoglobinemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DiclofenacapprovedPhase 427315307-86-53033
Synonyms:
(2,6-Dichlorophenyl)amino]benzeneacetic acid
15307-81-0 (mono-potassium salt)
15307-86-5
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-(2,6-Dichloroanilino)phenylacetic Acid
2-(2,6-Dichlorophenylamino)phenylacetic acid
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
2-[2-(2,6-Dichlorophenylamino)phenyl]acetic acid
2-[2-(2,6-dichloroanilino)phenyl]acetic acid
2b17
AC1L1F0T
AKOS001579542
Acetic acid, [o-(2,6-dichloroanilino)phenyl]- (8CI)
Allvoran
Apo-Diclo
Assaren
BIDD:GT0380
BPBio1_000516
BRD-K08252256-236-05-6
BRN 2146636
BSPBio_000468
BSPBio_002169
Benfofen
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)- (9CI)
C01690
CHEBI:47381
CHEMBL139
CID3033
Cambia
Cataflam
D07816
D30801
D3748
DB00586
DIF
Delphimix
Dichlofenac
Dichlofenal
Dichronic
Diclac
Diclo-Phlogont
Diclo-Puren
Diclobenin
Diclofenac
Diclofenac (INN)
Diclofenac Acid
Diclofenac Potassium
Diclofenac Sodium
Diclofenac [INN:BAN]
Diclofenac acid
Diclofenac potassium
Diclofenac sodium
Diclofenaco
Diclofenaco [INN-Spanish]
Diclofenacum
Diclofenacum [INN-Latin]
Diclofenamic acid
Diclomelan
Diclonate P
Diclophenac
Diclord
Dicloreum
Dicloreuma
Dicrofenac
DivK1c_000272
DivK1c_000402
Dolobasan
Duravolten
Dyloject
EINECS 239-348-5
Ecofenac
Effekton
Flector
GP-45,840
HMS2090C10
HMS501E04
HSDB 7234
 
I14-7739
IDI1_000272
IDI1_000402
ISV-205
KBio1_000272
KBio1_000402
KBio2_001410
KBio2_002306
KBio2_003978
KBio2_004874
KBio2_006546
KBio2_007442
KBio3_001389
KBio3_002786
KBioGR_001051
KBioGR_002306
KBioSS_001410
KBioSS_002308
Kriplex
LS-11575
Lopac0_000441
MolPort-000-003-072
N-(2,6-Dichlorop
NCGC00021125-01
NINDS_000272
NINDS_000402
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Oprea1_011155
Orthofen
Pennsaid
Prestwick0_000594
Prestwick1_000594
Prestwick2_000594
Prestwick3_000594
Primofenac
ProSorb-D
Prophenatin
Rhumalgan
SBB068617
SPBio_001081
SPBio_002687
SR-38
STK984493
Solaraze
Solaraze (TN)
Solaraze T
Spectrum2_000991
Spectrum3_000385
Spectrum4_000506
Spectrum5_000867
Spectrum_000930
Transfenac
Tsudohmin
UNII-144O8QL0L1
UNM000001216103
Valetan
Voldal
Voltaflan
Voltaren
Voltaren Ophtha
Voltaren Ophthalmic
Voltaren Rapide
Voltaren SR
Voltaren ophthalmic
Voltaren-XR
Voltarol
Xenid
Zipsor
Zorvolex
[2-(2,6-Dichloroanilino)phenyl]acetic acid
[o-(2,6-Dichloroanilino)phenyl]acetic acid
cMAP_000014
dichlofenac
diclofenac
henyl)-o-aminophenylacetic acid
{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
2AnalgesicsPhase 49358
3Peripheral Nervous System AgentsPhase 418510
4Antirheumatic AgentsPhase 48496
5Cyclooxygenase InhibitorsPhase 42225
6Anti-Inflammatory Agents, Non-SteroidalPhase 43549
7Analgesics, Non-NarcoticPhase 45184
8Anti-Inflammatory AgentsPhase 48478
9
Bevacizumabapproved, investigationalPhase 2, Phase 31875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
10Angiogenesis InhibitorsPhase 2, Phase 33688
11Angiogenesis Modulating AgentsPhase 2, Phase 33611
12Vaccines6085

Interventional clinical trials:

idNameStatusNCT IDPhase
1Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial EffusionCompletedNCT00247052Phase 4
2Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)TerminatedNCT02106520Phase 2, Phase 3
3Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern SenegalCompletedNCT01553552

Search NIH Clinical Center for Hemoglobinemia

Genetic Tests for Hemoglobinemia

About this section

Anatomical Context for Hemoglobinemia

About this section

MalaCards organs/tissues related to Hemoglobinemia:

33
Bone, Testes, Liver, Kidney, Breast, Ovary, Temporal lobe

Animal Models for Hemoglobinemia or affiliated genes

About this section

Publications for Hemoglobinemia

About this section

Articles related to Hemoglobinemia:

(show all 50)
idTitleAuthorsYear
1
Leukoencephalopathy and early death associated with an Ashkenazi-Jewish founder mutation in the Hikeshi gene. (26545878)
2016
2
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer. (26214624)
2015
3
Uterine inversion after an unskilled delivery - still a concern for maternal mortality: A case report and discussion of the related medico-legal issues. (26232213)
2015
4
Systemic mastocytosis with recurrent anaphylactic shock and multiple organ dysfunction failure. (25807653)
2015
5
Seroprevalence and risk factors of toxocariasis in preschool children in Aragua state, Venezuela. (26217045)
2015
6
Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report. (25179377)
2015
7
Prognostic factors in outcome of angioedema in the emergency department. (25295803)
2014
8
Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis. (22961311)
2013
9
Vascular disease: aortic plaque--dual therapy for a heterogeneous disease. (23712101)
2013
10
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in obese adolescents: A looming marker of cardiac dysfunction. (23913480)
2013
11
Gastrostomy feeding versus oral feeding alone for children with cerebral palsy. (23900969)
2013
12
LSHGD: a database for human leprosy susceptible genes. (22750101)
2012
13
Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. (22482717)
2012
14
Aldose reductase modulates cardiac glycogen synthase kinase-3I^ phosphorylation during ischemia-reperfusion. (22661511)
2012
15
Management of tick bites and lyme disease during pregnancy. (23231847)
2012
16
Distribution and regulation of the 25-hydroxyvitamin D3 1I+-hydroxylase in human parathyroid glands. (22326730)
2012
17
A case of childhood dermatofibrosarcoma protuberans of the face. (21763849)
2011
18
PharmGKB very important pharmacogene: SLCO1B1. (19952871)
2010
19
Improved growth and bone mineral density in type I trichorhinophalangeal syndrome in response to growth hormone therapy. (20569260)
2010
20
Neonatal outcome of gastroschisis is mainly influenced by nutritional management. (19367181)
2009
21
The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells. (19188365)
2009
22
Promoter methylation is associated with the age-dependent loss of N-cadherin in the rat kidney. (17959753)
2008
23
Delayed internalization and lack of recycling in a beta2-adrenergic receptor fused to the G protein alpha-subunit. (18840275)
2008
24
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. (18175285)
2007
25
Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. (17940983)
2007
26
Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. (16372352)
2006
27
Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? (15124262)
2004
28
A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway. (15465831)
2004
29
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. (15117841)
2004
30
Splenic marginal zone lymphoma. (12945935)
2003
31
Functional expression cloning reveals proapoptotic role for protein phosphatase 4. (12934076)
2003
32
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. (11222383)
2001
33
Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. (10719282)
2000
34
Antibody-based spot test for NADH-cytochrome b5 reductase activity for the laboratory diagnosis of congenital methemoglobinemia. (9620466)
1998
35
Prevalence of arylsulphatase A mutations in 11 Japanese patients with metachromatic leukodystrophy: identification of two novel mutations. (9819708)
1998
36
Therapy of acute myocardial infarct (1994-1996) at non-university hospitals in Switzerland (CHAMI Study)]. (9738274)
1998
37
Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. (9585721)
1998
38
Juvenile granulosa cell tumor of the ovary in infants: a clinicopathologic study of three cases and review of the literature. (9165474)
1997
39
Transcriptional activation domain of human BTEB2, a GC box-binding factor. (9089417)
1997
40
A study on the relationship between the production of cytokines and the biological features of cachexia using renal cell carcinoma heterotransplanted to nude mice]. (7897929)
1995
41
Alternative substrates for calf intestinal adenosine deaminase. A pre-steady-state kinetic analysis. (8428924)
1993
42
Polymerase chain reaction for detection of dissemination in gastric lymphoma. (2564509)
1989
43
Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. (3167282)
1988
44
Sirenomelia: mermaid syndrome. (3351972)
1988
45
CT diagnosis of synovial chondromatosis of the temporomandibular joint. (3492888)
1987
46
Nail-patella syndrome in an Indian family: clinical and linkage data. (5970338)
1966
47
A CASE OF GENERALIZED CHROMOBLASTOMYCOSIS. (14246016)
1964
48
Some interesting but rare disorders seen in pediatric practice with case report of Ritter's disease with recovery. (13502281)
1958
49
Granular cell myoblastoma of the vocal cord. (13114829)
1953
50
Penicillin treatment of dacryocystitis. (18132911)
1949

Variations for Hemoglobinemia

About this section

Expression for genes affiliated with Hemoglobinemia

About this section
Search GEO for disease gene expression data for Hemoglobinemia.

Pathways for genes affiliated with Hemoglobinemia

About this section

Pathways related to Hemoglobinemia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.3HBB, HP

GO Terms for genes affiliated with Hemoglobinemia

About this section

Biological processes related to Hemoglobinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to hydrogen peroxideGO:00425429.3HBB, HP
2receptor-mediated endocytosisGO:00068989.3HBB, HP

Sources for Hemoglobinemia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet